SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Company Shanghai Shyndec Pharmaceutical Co., Ltd.

600420

CNE000001JG2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-06-12			5-day change	1st Jan Change
8.710 ^CNY	+1.99%		-2.79%	-13.76%

05-22	Shyndec Pharma Gets Registration Certificate for Ibrutinib Capsules	MT
04-29	Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Business description: Shanghai Shyndec Pharmaceutical Co., Ltd.

Shanghai Shyndec Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company is mainly engaged in the research and development, production and sales of pharmaceutical intermediates and active pharmaceutical ingredients as well as drug preparations. The Company's products cover the therapeutic areas of systemic anti-infective, cardiovascular, anti-tumor and immunomodulators, central nervous system, hormones, urogenital system, digestive tract and metabolism, respiratory system and other fields. The Company is also engaged in animal vaccines, big health and other businesses, providing medical beauty products and skin care products. The Company distributes its products within the domestic market and to overseas markets.

Number of employees: 9,697

Sales by Activity: Shanghai Shyndec Pharmaceutical Co., Ltd.

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Pharmaceuticals Segment	13.94B	12.96B	12.07B	10.94B	9.36B

See all business segments

Geographical breakdown of sales: Shanghai Shyndec Pharmaceutical Co., Ltd.

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
East China	3.69B	3.68B	3.17B	2.81B	2.34B
Overseas	2.84B	2.49B	2.47B	2.58B	1.91B
Southern China	1.57B	1.2B	1.28B	1.11B	1.27B
North China	1.71B	1.75B	1.4B	1.5B	1.21B
Central China	1.25B	1.17B	1.13B	944M	919M
South-West China	1.47B	1.48B	1.26B	1.08B	876M
North-West China	564M	541M	573M	422M	401M
North-East China	669M	502M	514M	397M	398M

See all geographic segments

Executive Committee: Shanghai Shyndec Pharmaceutical Co., Ltd.

Manager	Title	Age	Since
Qian Yin Jing IRC	Investor Relations Contact	46	2019-09-12
Zhong Xi Zhang SEC	Corporate Secretary	50	2024-03-27

See SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. governance

Composition of the Board of Directors: Shanghai Shyndec Pharmaceutical Co., Ltd.

Director	Title	Age	Since
Yong Gang Xing CHM	Chairman	50	2019-11-24
Yong Liu BRD	Director/Board Member	57	2021-05-16
Zeng He Dong CHM	Chairman	60	2023-07-13
Shu Yuan Wei BRD	Director/Board Member	62	2020-05-28
Ying Qi Li BRD	Director/Board Member	50	2022-11-27
Ru Li BRD	Director/Board Member	47	2022-11-27
Xiang Dong Yu BRD	Director/Board Member	62	2019-01-30
Peng Wang BRD	Director/Board Member	44	2022-11-27
Fan Hong Wu BRD	Director/Board Member	58	2019-02-12
Kan Tian BRD	Director/Board Member	63	2019-02-12

Composition of the Board of Directors

Shareholders: Shanghai Shyndec Pharmaceutical Co., Ltd.

Name	Stocks	%	Valuation
China Southern Asset Management Co., Ltd. 0.4795 %	6,430,905	0.4795 %	9 M ¥
China Asset Management Co., Ltd. 0.4047 %	5,427,810	0.4047 %	7 M ¥
Fullgoal Fund Management Co., Ltd. 0.1349 %	1,808,800	0.1349 %	2 M ¥
China Merchants Fund Management Co., Ltd. 0.1237 %	1,658,605	0.1237 %	2 M ¥
Tian Hong Asset Management Co., Ltd. 0.1125 %	1,508,600	0.1125 %	2 M ¥

List of SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. shareholders

Company details: Shanghai Shyndec Pharmaceutical Co., Ltd.

Shanghai Shyndec Pharmaceutical Co., Ltd.

378 Jianlu Road

200137, Shanghai

+86 21 6251 0990

http://www.shyndec.com

address Shanghai Shyndec Pharmaceutical Co., Ltd.(600420)

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+1.99%	-2.79%	-19.58%	-21.32%	1.73B
MERCK & CO., INC.	-1.42%	-1.44%	+45.70%	+8.24%	294B
MERCK KGAA	-1.59%	-2.63%	+16.07%	-20.92%	67.08B
HALOZYME THERAPEUTICS, INC.	-1.74%	-2.84%	+28.75%	+105.32%	8.24B
KYOWA KIRIN CO., LTD.	-1.15%	+4.87%	-3.58%	-12.17%	7.84B
SK BIOPHARMACEUTICALS CO., LTD.	-0.68%	-0.23%	-2.66%	+8.52%	4.54B
YUHAN CORPORATION	+1.05%	-0.39%	-27.51%	+33.10%	3.8B
BETTA PHARMACEUTICALS CO., LTD.	+2.01%	+10.19%	-14.95%	+8.11%	3.35B
SUPERNUS PHARMACEUTICALS, INC.	-2.50%	-0.76%	+38.65%	+31.12%	2.58B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+3.11%	+1.30%	+5.67%	-22.84%	1.98B
Average	-0.09%	+2.34%	+6.66%	+11.72%	39.52B
Weighted average by Cap.	-1.36%	-1.24%	+37.03%	+5.01%